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Background:  The S100 family consists of small acidic proteins, belonging to
the EF-hand class of calcium-binding proteins. They are primarily regulatory
proteins, involved in cell growth, cell structure regulation and signal
transduction. Psoriasin (S100A7) is an 11.7 kDa protein that is highly up-
regulated in the epidermis of patients suffering from the chronic skin disease
psoriasis. Although its exact function is not known, psoriasin is believed to
participate in the biochemical response which follows transient changes in the
cellular Ca2+ concentration.
Results:  The three-dimensional structure of holmium-substituted psoriasin has
been determined by multiple anomalous wavelength dispersion (MAD) phasing
and refined to atomic resolution (1.05 Å). The structure represents the most
accurately determined structure of a calcium-binding protein. Although the overall
structure of psoriasin is similar to those of other S100 proteins, several important
differences exist, mainly in the N-terminal EF-hand motif that contains a distorted
loop and lacks a crucial calcium-binding residue. It is these minor differences that
may account for the different specificities among members of this family.
Conclusions:  The structure of human psoriasin reveals that this protein, in
contrast to other S100 proteins with known structure, is not likely to strongly
bind more than one calcium ion per monomer. The present study contradicts
the idea that calcium binding induces large changes in conformation, as
suggested by previously determined structures of apo forms of S100
proteins. The substitution of Ca2+ ions in EF-hands by lanthanide ions may
provide a general vehicle for structure determination of S100 proteins by
means of MAD phasing.
Introduction
The S100 protein family is the largest subfamily of
EF-hand proteins, originally characterized as being soluble
in 100% ammonium sulphate. This was merely true,
however, for the first two proteins discovered in 1965,
S100B and S100A1 [1], and is no longer a common
feature among the 17 members identified so far. The
S100 proteins are all abundant, low molecular weight
(10–12 kDa), acidic proteins [2] that exhibit extremely
tissue-specific expression. Most of these proteins exist as
dimers under physiological conditions.
The sequence homology between members of the group
is typically about 50% and they all share important primary
sequence features, such as several conserved hydrophobic
residues and the residues involved in calcium binding.
The S100 proteins normally contain two EF-hands, one
canonical EF-hand (at the C terminus) and one variant (at
the N terminus), both which are flanked by highly con-
served hydrophobic regions. The term canonical EF-hand
refers to the high affinity binding mode of calcium as
described by Tufty and Kretsinger in an early paper [3],
for which the ion is bound by sidechain oxygen atoms of
mostly acidic residues, whereas calcium binding by the
variant hand primarily involves mainchain oxygen atoms.
One of the most variable parts of the S100 proteins seems
to be the central hinge region that often is a helix connect-
ing the two EF-hand motifs. This hinge region could be
crucial to any conformational changes that relate to the
function of the proteins because the EF-hands themselves
must be conserved in order to bind calcium, as must the
terminal hydrophobic regions to preserve the dimerization
of the molecule. In contrast to the canonical EF-hand, the
N-terminal hand of many S100 proteins has an insertion of
two amino acids in the calcium-binding loop, an alteration
that apparently lowers the calcium affinity by at least an
order of magnitude [4].
Structural information is available for several S100 proteins,
including bovine apo S100B [5], rabbit lung apo S100A6
(also called calcyclin; [6]) and calbindin D9k. The struc-
tures of S100B and S100A6 have been determined by low
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resolution nuclear magnetic resonance (NMR). Further-
more, the crystallization of S100B with and without Ca2+
has been reported [7]. Several structures of calbindin D9k
have been determined both by X-ray crystallography [8]
and NMR spectroscopy [9,10], thus representing the best
studied member of the family. Calbindin D9k differs from
the other S100 proteins, being shorter (78 residues versus
90–100) and being the only S100 protein that does not
dimerize [8–10]. The physiological role of the protein is also
somewhat different in that it appears to work merely as a
calcium buffer that is involved in the regulation of cellular
calcium levels, rather than a regulatory protein. The solu-
tion structures of apo S100B and apo S100A6 describe
similar globular homodimers, consisting of purely helical
secondary structure. Differences between the structures
are, for example, the angles between helices and the exis-
tence, or lack, of a linker helix in the central region. Both
structures have been determined from the apo form of the
proteins, yet it is argued that all oxygen ligands are correctly
oriented for calcium binding. Determination of homodimer
structures by means of NMR is significantly hampered,
however, by the fact that it is often impossible to distin-
guish among inter- and intramonomer NOEs unless cross-
labeling is used. This means that it is imperative to initially
determine the structure of a single monomer and then man-
ually dock the monomers together to fit the rest of the dis-
tance restraints. Because of this and the fact that differences
among the S100 proteins are most likely to be, for example,
small variations of conserved residues and in the angles
between helices, an accurate crystal structure of a typical
S100 protein is needed.
This paper reports the atomic resolution (1.05 Å) crystal
structure of human psoriasin determined by multiple
wavelength anomalous dispersion (MAD) phasing. In
order to introduce an anomalous scatterer in the protein,
the intrinsic calcium ions of the EF-hands were substi-
tuted for a heavier lanthanide element, holmium (67Ho).
Trivalent lanthanide cations (La3+) all show similar physi-
cal and chemical properties and have ionic radii and pre-
ferred coordination similar to that of Ca2+. Substitution of
Ca2+ ions bound in proteins for La3+ ions has been per-
formed successfully a number of times [11–13] and it is
generally accepted that this substitution does not signifi-
cantly alter the conformation of the proteins in question.
Substitution of the intrinsic calcium ions by lanthanide
ions is now proposed as a general vehicle for structure
determination of S100 proteins by means of MAD phasing.
The crystallographic phase information which has become
available through the reported MAD experiment is excep-
tionally good and the quality of the data allowed refine-
ment of the model to atomic resolution. The overall struc-
ture is similar to the previously described general fold of
the S100 proteins and indeed seems to be a homodimer
structure, even though psoriasin also differs significantly
from other S100 proteins in several ways.
Results and discussion
MAD experiment and structure determination
The intrinsic calcium ions located in the EF-hands of the
protein were substituted for Ho3+ prior to the crystalliza-
tion to obtain a protein with a strong anomalous scatterer
present. The incorporation of the heavy element was
achieved through a biochemical procedure in which the
protein initially was denatured by use of urea. Subse-
quently, divalent cations (Ca2+) were removed by use of
ethylenediaminetetracetate (EDTA) and the new cation
(Ho3+) was added at acidic pH in a solution saturated with
He, in order to prevent formation of holmium hydroxides
of low solubility. Finally, the protein was renatured upon
removal of the urea by gel filtration, thus fixing the lan-
thanide ion tightly within the EF-hands of the protein.
The procedure presented here may be applicable to other
calcium-binding proteins and particularly to other pro-
teins belonging to the S100 family. Due to the relatively
small size of the S100 proteins and the strong fixation of
the lanthanide ion within the EF-hand, the phasing of
such data by application of multiple wavelength experi-
ments is expected to be excellent. 
Orthorhombic crystals of the holmium-substituted psoriasin
appeared as long rods or needles in sitting drops that had
equilibrated a few days at room temperature. The crystals
belong to the spacegroup P212121 with cell dimensions
a = 46.83 Å, b = 61.14 Å, c = 62.49 Å, and were obtained in
polyethyleneglycol monomethylether (PEGmmes) 2000
and ammonium sulphate. These conditions vary consid-
erably compared with those used for the native, calcium-
binding, form of the protein which was previously crys-
tallized in our laboratory without significant amounts of
salt present apart from additives (P212121, a = 52.15 Å,
b = 56.67 Å, c = 76.38 Å) [14]. Due to the apparent lack of
isomorphism between the crystals of the native protein and
the holmium-substituted protein, determination of the
structure by the method of single isomorphous replacement
using anomalous scattering (SIRAS) was effectively pre-
cluded. Characterization of the psoriasin crystals was done
using the in-house FAST area detector, which operates a
rotating anode emitting CuKa radiation. As the wavelength
of the copper line spectrum X-rays (1.54 Å) is very close to
the holmium LIII absorption edge at 1.536 Å, considerable
anomalous signal was detected and it was decided that the
crystals of the holmium-substituted protein were suitable
for a MAD experiment.
The X31 beamline at the EMBL (Hamburg), situated on
the bending magnet D1/2 of DORIS III, is a low-inten-
sity synchrotron beamline, but is tunable in the range
0.68 Å–2.0 Å. This wavelength range and the high energy
resolution of 2–5 · 10–4 D E/E make the beamline suit-
able for structure determination via the MAD method.
Due to technical limitations of the double monochroma-
tor at the X31 beamline, it was not possible to collect
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MAD data at the strong LIII-edge at 1.54 Å, which is the
only absorption edge of holmium that has previously
been used for MAD phasing. The structure presented in
this paper was determined using the anomalous and dis-
persive signal at the holmium LII-absorption edge at
approximately 1.4 Å, and the structure was solved exclu-
sively from phasing with these MAD data collected from
the orthorhombic crystals. The fluorescence scan
recorded from a single crystal revealed a large white-line
(a great enhancement of the anomalous signal at the
absorption edge), which is a typical feature of lanthanide
L-edges. This allowed for calibration of the monochro-
mator and facilitated an accurate choice of the wave-
lengths to aim for. A complete three-wavelength MAD
data set was collected on a single crystal at cryogenic
temperature using the traditional peak, edge (inflection
point) and high energy remote wavelengths (Table 1).
Due to the natural rod-shape of the crystals, a quasi-
alignment with the rotation axis close to parallel to the
longest edge of the rods was used in order to record
Friedel mates on nearby frames, while still avoiding a
large spin angle cusp. Apart from the above, none of the
traditional approaches for recording Friedel mates close
in time (like the ‘inverse-beam’ approach) were applied,
and the three data sets were recorded one at a time.
Owing to the significant white-line of the lanthanide
L-edges, both Bijvoet and dispersive difference Patterson
maps calculated for the MAD data set were almost noise-
free and could readily be solved to obtain the positions of
the anomalous scatterers in the unit cell. Table 2 shows
the relative contribution of the anomalous and dispersive
differences to the total scattering as well as the refined
scattering factors for the three wavelengths. For each
asymmetric unit, two holmium positions were found corre-
sponding to either a single molecule with two holmium
ions or two molecules each with one holmium ion.
An almost complete set of accurate experimental phases
was obtained to a resolution of 1.9 Å spacings from the
MAD data, using the program MLPHARE [15]. The
phasing strategy can be described as ‘merge first, phase
later’ and is traditional in the sense that none of the
program packages specifically written for MAD phasing
(like MADSYS [16] or SHARP [17]) were applied during
the phasing. SHARP was used, however, for refinement of
the scattering factors, as these are significantly biased by
data scaling and heavy-atom occupancies when running
MLPHARE. The three data sets were thus treated as
three independent derivatives for which the edge wave-
length (minimum of f¢ ) was taken as the reference or native
data set [18]. The phasing of the data was excellent with an
overall figure of merit of about 0.8 and a very low lack of
closure as judged from the values for Rcullis (Table 2). An
initial electron-density map was then calculated from the
observed |FT| at the edge wavelength and the calculated
phases, j T. The hand of the heavy-atom substructure
could now be determined, as only one of the two enan-
tiomer substructures resulted in a clear protein–solvent
boundary, whereas the other just gave featureless electron
density. Refinement of heavy-atom parameters with the
maximum-likelihood program SHARP [17] provided pre-
cisely refined scattering factors, as well as a more correctly
estimated measure of the figure of merit. The quality of
the initial experimental map was exceptionally good as
expected from the phasing statistics. All mainchains and
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Table 1
Overall data collection statistics.
Wavelength (Å) 1.3887 1.3893 0.98 0.9091
Peak l 1 Edge l 2 Remote l 3 High resolution
Beam line X31 X31 X31 X11
Temperature (K) 100 100 100 100
Detector MAR 18cm MAR 18cm MAR 18cm MAR 30cm
Resolution (Å) 14.9–1.9 14.9–1.9 16.2–1.7 37.5–1.05
Reflections 125,593 124,311 195,994 700,858
13,605 (unique) 13,583 (unique) 20,430 (unique) 84,591 (unique)
Cell (Å) a = 46.83 a = 46.81
b = 61.14 b = 61.63
c = 62.49 c = 62.77
Average redundancy 2.3 2.5 2.5 1.8
Completeness (%)* 97.5 (87.6) 97.7 (90.1) 98.8 (89.4) 97.9 (84.1)
Rsym (%)*† 5.1 (15.1) 5.4 (15.9) 4.2 (16.3) 4.3 (10.1)
I/s I* 17.8 (12.1) 17.1 (11.3) 22.4 (10.7) 28.8 (4.7)
*Values in parentheses correspond to the outermost resolution shell
(2.00–1.94, 2.01–1.94, 1.74–1.70 and 1.07–1.05, from left to right
across the table). †Rsym = (å |Ihkl–<I>|)/(å Ihkl), where the average
intensity <I> is taken over all symmetry equivalent measurements and
Ihkl is the measured intensity for any given reflection.
sidechains except for a few terminal residues could imme-
diately be modelled in the initial density even without any
kind of phase improvement/extension, such as solvent flat-
tening or other kinds of density modification. Figure 1a
shows the initial, purely experimental, MAD electron-
density map, whereas Figure 1b illustrates the final, refined,
map to 1.05 Å.
The structure has been refined against a high resolution
data set collected to 1.05 Å spacings at the somewhat
stronger X11 beamline at the EMBL (Table 1). The
initial refinement of the structure was done with the
program TNT [19], but the model was transferred to
SHELX-97 [20,21] when using the atomic resolution
data. The refined model includes double conformers for
19 residues in the asymmetric unit, an individual and
anisotropic B-factor model as well as riding hydrogen
atoms. The average isotropic equivalent B factor for the
protein atoms is 16.7 Å2. The final model includes all 200
residues in the asymmetric unit and 387 solvent mol-
ecules with refined occupancies, giving an overall crystal-
lographic R factor for all data of 10.49% and a cross-
validation Rfree of 14.12% (no s -cutoff). Figure 1b shows
the final s A-weighted 2Fo–Fc electron density map [22]
and Table 3 gives a summary of the final model. The
final Fourier map is of such quality that for the vast
majority of the residues in the model, each atom is
clearly separated from its neighbors. For several of the
mainchain and sidechain atoms throughout the helices,
individual hydrogen atoms are visible at 1.8s in an
s A-weighted Fo–Fc difference map that was calculated
before the riding hydrogens were added in the calculation
of the Fc (Figure 1c).
Description of the structure
Most of the S100 proteins exist as almost complete, non-
covalent, homodimers in solution, and some of them even
form heterodimers with other members of the family [2].
This homodimerization is also very clear from the crystal
structure of psoriasin, in which the two molecules in the
asymmetric unit wrap tightly around each other stabilized
by a beautiful helical packing. As already evident from the
number of peaks in the anomalous Patterson, each mol-
ecule contains only one metal-ion-binding EF-hand. This
could be an artifact caused by the cation substitution, but
for several reasons described below, it is unlikely that the
native protein contains more than a single EF-hand that
binds calcium with significant affinity. EF-hands are
usually found in pairs, although the recently solved struc-
ture of calpain revealed that this protein contains five EF-
hands [23]. In that particular structure, however, the fifth
EF-hand participates in the homodimerization and is
thereby also associated with a nearby helix.
The structure of psoriasin is, except for the common
single-residue stretch of b -sheet type interaction between
the loops of the two EF-hands, a pure a -domain structure
in which only loop regions without clear secondary struc-
ture connect the helices (Figure 2). Each monomer con-
sists of five a helices which have been designated I–IV+II¢ .
Two by two of these participate in the EF-hand helix–
loop–helix motifs, in such a way that I+II is the N-terminal
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Table 2
Analysis of the MAD signal.
Observed diffraction ratios* Scattering factors†
l 1 l 2 l 3 f¢ (e–) f¢¢ (e–)
l 1 (peak) 0.182 (0.047) 0.046 0.107 –14.5 16.7
l 2 (edge) 0.136 (0.048) 0.119 –17.9 11.5
l 3 (remote) 0.098 (0.040) –5.0 6.4
Phasing power‡ 1.11 (0.75) –(–) 2.34 (1.38)
Rcullis§ 0.73 (0.76) –(–) 0.52 (0.58)
Rcullis, anomalous§ 0.33 0.42 0.46
Overall FOM#
acentric 0.82
centric 0.64
all 0.79
*Values given are the average contribution of the MAD signal and
represent <D |F|2>½ / <|F|2>½, where D |F| is the Bijvoet difference
(diagonal elements) or dispersive difference (off-diagonal elements).
The values in parentheses represent the centric reflections only and
can be taken as a measure of the noise in the values next to them, as
they theoretically should be zero. The noise estimates are based on a
s -cutoff of 2.0. †The scattering factors have been refined with SHARP
[17], for which the f´ at the remote wavelength was fixed to –5.0 as a
reference. Phasing was carried out with the CCP4 program MLPHARE
(see text). ‡The phasing power is calculated as <FA> / <phase
integrated lack of closure>. Values have been calculated for all
reflections and for the centric reflections only (in parentheses). §Rcullis
is defined as <phase integrated lack of closure> / <dispersive or
anomalous difference> for Rcullis or Rcullis(anomalous), respectively. #FOM
is the figure of merit without any kind of density modification.
EF-hand, II´ is the linker helix and III+IV is the C-termi-
nal EF-hand. Starting at the N terminus and working
through the structure towards the C terminus, each
monomer begins with the empty N-terminal EF-hand
where the four-turn helix I (from Gln4 to Lys18) leads into
the first loop (Tyr19–Asp27) and the next three-turn helix
II (Lys28–Phe39). At this point, a proline residue (Pro40)
leads to a break in the regular helical pattern and the
smaller 2½-turn linker helix II¢ (Asn41–Lys48) starts off in
a somewhat different direction. After passing through a
small coil region, the canonical EF-hand motif begins with
the two-turn helix III from Tyr53 to Lys61, the calcium-
binding loop from Asp62 to Asp70, and finally the long and
perfect five-turn helix IV from Phe71 to Gln88. The main-
chain then makes a bend at Gly91 and terminates with the
C terminus situated inside a small cavity between helices
IV, III and II¢ . Residues 95–100 define a more or less flexi-
ble tail that reaches into the solvent region. The last two
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Figure 1
Electron-density maps of psoriasin (S100A7).
(a) Stereo pair of the initial electron density as
it appeared directly after phasing with
MLPHARE to 1.9 Å. This map has not been
subjected to any kind of density modifications
such as solvent flattening. The central residue
is Tyr85 in monomer B. Contouring is purple
(1.5s ) and white (2.5s ). (b) The final s A-
weighted 2Fo–Fc map, calculated to 1.05 Å,
showing the same region as above.
Contouring is purple (2.2s ) and white (3.6s ).
(c) A plot of the final 2Fo–Fc electron density
around residue IleB26, along with the Fo–Fc
difference density before introduction of the
riding hydrogen model. For this isoleucine
residue, six of a total of nine hydrogen atoms
are clearly visible in the difference density.
Contouring is purple (2Fo–Fc, 3.6s ) and white
(Fo–Fc, 1.8s ).
residues (99–100) of one of the two monomers in the asym-
metric unit appear weak in the density, supposedly due to
high mobility.
Presumably because of the lack of strong protein–ligand
interactions in the empty N-terminal helix–loop–helix
motif, helix I diverges from the common near-parallel
alignment with its neighboring helix (II) and thereby
makes the entire N terminus bend away from the rest of
the structure. This means that each monomer by itself is
highly non-globular, and might be a reason why two
monomers associate as a natural dimer. In the dimer,
helices I from the two monomers pack against each other
in an antiparallel manner that results in a tight helical
packing of helices I, II, and IV in the dimer. In fact, at the
‘bottom’ of the dimer, the two long helices IV pack
together in a similar antiparallel fashion as the two helices
I, only perpendicular to these and flanked by the helices
II, II ¢ and III on each side (Figure 2b), making the overall
structure look like a hash mark (#) from the top. The two
long helices IV bend around each other in this tight
packing. If the dimer is viewed from the side (Figure 2a),
it is evident that the protein has a clamp-like shape and
appears adapted to wrap around something with its two
EF-hand protrusions. We propose that the protein in its
natural environment could act by binding to its target pro-
teins by means of this binding cleft. For several of the
other EF-hand proteins, the Ca2+ concentration in the cell
is known to be a strong determinant of the activity of the
proteins. On this basis, it is possible that the activity of
psoriasin could be regulated through binding–release of
the two calcium ions in the dimer that both are situated in
close vicinity to the putative binding cleft.
The location of the a helices in the psoriasin amino
acid sequence is shown schematically in Figure 3, which
also compares psoriasin with the secondary structures of
S100B, S100A6 and calbindin D9k. As is evident from this
figure, the lengths and positions of the a helices in psori-
asin most closely resemble those in S100B, whereas
S100A6 is somewhat different because it lacks the linker
helix II ¢ between helices II and III. When the structures
of S100B and S100A7 are compared, it is evident that the
linker helix IV ¢ in S100B (which corresponds to helix II ¢
in psoriasin) is a small and distorted (one turn) helix
leading up to the longer three-turn helix III that is part
of the C-terminal EF-hand. In psoriasin, however, this
situation is reversed, because in this case helix III (which
is composed of two turns and is part of the canonical EF-
hand) is smaller and somewhat distorted, and the linker
helix II ¢ is the regular helix.
Sequence homology
The sequence homology among most of the S100 proteins
is high, often between 40–50% [2]. They are all of approx-
imately the same size and the alignment of the primary
sequence of these proteins is generally good, aligning the
two calcium-binding loops and the conserved hydrophobic
residues in all cases. The sequence homology between
psoriasin and the other S100 proteins is lower than the
average for the family, however — 27.3% with S100B and
25.0% with S100A6. The sequence homology between
S100B and S100A6 is much higher, 44.2%. The primary
sequence of psoriasin differs in several important ways
from the rest of the S100 family, as is also evident from
Figure 3 which shows a sequence alignment of psoriasin
and the other known S100 proteins.
As for the canonical C-terminal EF-hand, psoriasin contains
most of the residues needed for calcium-binding by means
of this canonical EF-hand. Although the structure of the
EF-hand differs by having a long and floppy lysine residue
at the position denoted * in Figure 3 (where both S100B and
S100A6 and most of the other S100 proteins have a gluta-
mate or glutamine), the domain structure probably remains
unaffected, as the calcium is coordinated by a mainchain
oxygen atom at this position. In the N-terminal half of the
sequence, however, the overall homology is much lower.
Many of the residues which are conserved between
S100B and S100A6 are different or not even conservatively
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Table 3
Summary of the final model.
No. of reflections used in refinement 160,437
No. of parameters refined 18,753
Resolution range (Å) 37.5–1.05
No. of atoms in the model
non-hydrogen 1649
hydrogen 1397
water 387
Crystallographic R factor (%) 10.49
Cross-validating Rfree (%) 14.12
No. of residues with disorder 19
B-factor model individual but restrained,
anisotropic
Average equivalent isotropic B factor*
mainchain (Å2) 13.3/14.4
sidechain (Å2) 16.1/18.3
water (Å2) 37.4
Ramachandran plot statistics†
most favored regions (%) 92.1
additional allowed regions (%) 7.9
generously allowed regions (%) 0.0
disallowed regions (%) 0.0
Overall G factor† 0.11
*The values shown are the corresponding isotropic B factors
calculated from the anisotropic U matrix; for mainchain and
sidechain, the two numbers represent values for monomers A and B
in the asymmetric unit, respectively. †The Ramachandran plot and
G factor have been calculated with PROCHECK [36]. The G factor
is the weighted average of the log-odds score as described in the
PROCHECK documentation. Values below –1.0 may indicate a
problem structure. The values for root mean square deviations from
ideality have deliberately been left out of this summary, because they
have little relevance to structures solved at purely atomic resolution.
changed in the psoriasin sequence. It is clear that with
respect to primary sequence, psoriasin differs from the rest
of the S100 proteins, particularly at the N terminus.
The EF-hand loops
The calcium-binding loop in the C-terminal EF-hand
of psoriasin complies with most of the strict primary
sequence requirements in the canonical EF-hand, as
suggested by Tufty and Kretsinger ([3]; Figure 3). Gen-
erally, the calcium-binding loops of the two monomers
are extremely well defined and show very little thermal
disorder (B » 10 Å2 for the mainchain atoms as well as the
holmium atoms). This means that the cation in the loop
is kept fixed by the seven oxygen ligands around it (Asp62,
Asn64, Asp66, Lys68, two oxygen atoms from Glu73 and
a solvent molecule). Moreover, there does not seem to be
any significant anisotropic motion in this part of the mol-
ecule. For the known structures of S100B and S100A6,
determined by NMR, the standard deviation of the
atomic positions of these structures is significant, with a
root mean square deviation (rmsd) for backbone atoms of
S100B of 0.74 Å, roughly corresponding to a crystallo-
graphic B factor of 40 Å2. Actually, in many cases only
the helices are well-defined and Potts et al. [6] even con-
clude that the calcium-binding loops are poorly defined
in the structure of S100A6 and that an in-depth analysis
therefore is precluded.
The sequences of the C-terminal EF-hand of most of the
S100 proteins deviate from the canonical Tufty and
Kretsinger sequence ([3]; not shown) at several positions.
According to this, residue 53 in psoriasin would be expected
to be a glutamate but is a tyrosine, located as the first
residue in helix III, not close to the critical calcium-
binding site, and is probably not crucial with respect to
calcium affinity. Moreover, the canonical sequence sug-
gests that a hydrophobic residue should occupy position
61, but this is evidently not the case in psoriasin — with a
lysine in this position. It is more interesting that the
glycine between the positions denoted Z and –Y in the
canonical sequence (Figure 3), which is important for the
turn of the loop, has been substituted for a lysine in
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Figure 2
Overview of the psoriasin structure. (a) A
ribbon representation of the side view of
psoriasin, viewing the structure perpendicular
to the twofold non-crystallographic axis (i.e.
rotated 90° around the horizontal axis with
respect to the view below). The monomers A
and B have been colored blue and green,
respectively, and helices have been labelled
from I through IV. The two Ho atoms are
shown in magenta along with the residues
that make up part of the holmium coordination
(residues Asp62, Asn64, Asp66, Lys68 and
Glu73). Between the two EF-hands, the
putative binding cleft for receptor type
molecules is evident in the lower part of the
figure. Figure produced with MOLSCRIPT
[39] and Raster3D [40,41]. (b) Stereo pair of
a Ca trace of the structure with colors ranging
from red (N termini) to blue (C termini) for
both monomers. Every tenth Ca atom is
labeled for monomers A and B. Figure
produced with oplot [33].
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psoriasin. In the structure of psoriasin, the sidechain of
this lysine is pointing away from the metal ion and thus
allows the loop to turn, even with such a bulky sidechain
at this critical position. Consequently, it can be ques-
tioned whether the glycine really is a crucial part of the
canonical motif or whether lysine might have been intro-
duced into psoriasin for specific functional reasons.
As expected from the structural generality among the
S100 proteins that was proposed upon determination of
the structures of S100B and S100A6 [5,6], the overall fold
of psoriasin is similar to these proteins, being a four-helix
bundled, non-covalent, dimer. There are, however, impor-
tant differences among the three structures as will be
described below, differences that may lead to a further
understanding of how the many similar calcium-binding
mediator proteins in the cell distinguish their cognate
target molecules from other proteins.
The major primary sequence differences between psori-
asin and other S100 proteins is a three-residue gap in the
alignment, found within the variant EF-hand motif
(Figure 3). From a structural point of view, psoriasin also
differs at its N-terminal EF-hand. Figure 4a shows an
alignment of the Ca positions of this helix–loop–helix
motif from psoriasin with motifs from similar proteins.
Notice in the figure how the gap of three amino acids in
the empty loop of psoriasin forces the loop to ‘cut short’
and continue into the next helix, at a point where the
canonical motif loops around the bound calcium ion. Con-
sequently, the loop appears considerably distorted and
would not be able to bind calcium in a way similar to the
other S100 proteins. Moreover, psoriasin lacks the impor-
tant bidentate glutamate at position 30 (which is replaced
with a serine) that is supposed to coordinate calcium with
both of its sidechain oxygen atoms. Conclusively, psori-
asin is probably not able to bind calcium in its low-affinity
site, and thus contains only one calcium-binding EF-hand.
If the holmium-binding C-terminal loop of psoriasin is
structurally aligned with the corresponding motif from the
apo structure of S100B (Figure 4b), it is immediately
evident that the helices in psoriasin are oriented at ~30° to
each other, whereas the two helices in S100B appear
almost parallel. Moreover, the incoming helix (helix III) in
the psoriasin motif is short and distorted and connected to
a helical segment (helix II¢ ), perpendicular to the plane of
the paper near the residue A44. Even though one must
keep in mind that this could be an artifact of two different
proteins with different amino acid sequences, it could be
minor changes such as these that control the function of
the protein upon calcium binding in vivo. If the entire
molecules of psoriasin and S100B (or S100A6) are aligned,
the overall shape and structure of the two is almost identi-
cal. It therefore seems likely that minor changes such as
the above mentioned are related to the different functions
of the proteins.
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Figure 3
A multiple sequence alignment of the known
S100 proteins. All sequences represent the
human genome, except for S100A6, S100B
and calbindin D9k that are from rabbit lung
reticulocyte, bovine and bovine intestine,
respectively. The red bars indicate the
location and extent of the a helices at the
N-terminal EF-hand (I+II), the linker helix in
some cases (II¢ ) and the C-terminal EF-hand
(III+IV). The color coding shows whether a
given residue is conserved (> 50%, blue),
highly conserved (> 90%, red), or is part of a
flanking conserved hydrophobic region
(magenta). The location of the calcium-
coordinating oxygen atoms is indicated using
the classic Tufty and Kretsinger notation, for
which † is a monodentate sidechain oxygen, ‡
is a bidentate sidechain oxygen, * is a
mainchain oxygen and w is a water molecule.
For the consensus symbols, $ is either leucine
or methionine, % is either phenylalanine or
tyrosine, and # any of asparagine, aspartate,
glutamine or glutamate. Upper case letters in
the consensus sequence indicate fully
conserved residues, whereas lower case
indicate partial conservation. The alignment
was calculated with MultAlin [42], using the
blosum62 symbol comparison table. 
                                         I                           II          II’
   S100A7  .......... ........SN TQAERSIIGM IDMFHKYTRR D...DKIDKP SLLTMMKENF PNFLSACDKK
                                                   *   * *  * w   ‡
   S100A6  .......... ........MA SPLDQAIGLL IGIFHKYSGK EGDKHTLSKK ELKELIQKEL T..IGS..KL
    S100B  .......... .......... SELEKAVVAL IDVFHQYSGR EGDKHKLKKS ELKELINNEL SHFLEE..IK
      D9k  .......... .......... .SAKKSPEEL KGIFEKYAAK EGDPNQLSKE ELKLLLQTEF PSLL.....K
   S100A1  .......... .........G SELETAMETL INVFHAHSGK EGDKYKLSKK ELKELLQTEL SGFLDA..QK
   S100A2  .......... ........MC SSLEQALAVL VTTFHKYSCQ EGDKFKLSKG EMKELLHKEL PSFVGE..KV
   S100A3  .......... ........MA RPLEQAVAAI VCTFQEYAGR CGDKYKLCQA ELKELLQKEL ATWTPT..EF
   S100A4  .......... ........MA CPLEKALDVM VSTFHKYSGK EGDKFKLNKS ELKELLTREL PSFLGK..RT
   S100A5  MPAAWILWAH SHSELHTVME TPLEKALTTM VTTFHKYSGR EGSKLTLSRK ELKELIKKEL C..LG...EM
   S100A8  .......... ........ML TELEKALNSI IDVYHKYSLI KGNFHAVYRD DLKKLLETEC PQYIRK....
   S100A9  .......... .....MTCKM SQLERNIETI INTFHQYSVK LGHPDTLNQG EFKELVRKDL QNFLKK.ENK
  S100A10  .......... .........P SQMEHAMETM MFTFHKFAGD KGY...LTKE DLRVLMEKEF PGFLEN..QK
  S100A11  .......... ...MAKISSP TETERCIESL IAVFQKYAGK DGYNYTLSKT EFLSFMNTEL AAFTKN..QK
  S100A12  .......... .......... TKLEDHLEGI INIFHQYSVR VGHFDTLNKR ELKQLITKEL PKTLQN..TK
Consensus  .......... .......... ..le.a.... i..%hk%s.. .g....l.k. elk.$...#l p..l.....k
                  III                      IV
   S100A7  GTNYLADVFE KKDKNEDKKI DFSEFLSLLG DIATDYHKQS HGAAPCSGGS Q.........
                        † † † *  w  ‡
                        X Y Z-Y -X -Z
   S100A6  QDAEIVKLMD DLDRNKDQEV NFQEYITFLG ALAMIYNEAL KG........ ..........
    S100B  EQEVVDKVME TLDSDGDGEC DFQEFMAFVA MITTACHEFF EHE....... ..........
      D9k  GPSTLDELFE ELDKNGDGEV SFEEFQVLVK KISQ...... .......... ..........
   S100A1  DVDAVDKVMK ELDENGDGEV DFQEYVVLVA ALTVACNNFF WENS...... ..........
   S100A2  DEEGLKKLMG NLDENSDQQV DFQEYAVFLA LITVMCNDFF QGCPDRP... ..........
   S100A3  RECDYNKFMS VLDTNKDCEV DFVEYVRSLA CLCLYCHEYF KDCPSEPPCS Q.........
   S100A4  DEAAFQKLMS NLDSNRDNEV DFQEYCVFLS CIAMMCNEFF EGFPDKQPRK K.........
   S100A5  KESSIDDLMK SLDKNSDQEI DFKEYSVFLT MLCMAYNDFF LEDNK..... ..........
   S100A8  ..KGADVWFK ELDINTDGAV NFQEFLILVI KMGVAAHKKS HEESHKE... ..........
   S100A9  NEKVIEHIME DLDTNADKQL SFEEFIMLMA RLTWASHEKM HEGDEGPGHH HKPGLGEGTP
  S100A10  DPLAVDKIMK DLDQCRDGKV GFQSFFSLIA GLTIACNDYF VVHMKQKGKK ..........
  S100A11  DPGVLDRMMK KLDTNSDGQL DFSEFLNLIG GLAMACHDSF LKAVPSQKRT ..........
  S100A12  DQPTIDKIFQ DLDADKDGAV SFEEFVVLVS RVLKTAHIDI HKE....... ..........
Consensus  .....d..m. .lD.#.Dg.v .F.E%..l.. ....a.h... .......... .......... Structure
The disulphide bridge
It has been discussed ([6] and references therein)
whether disulphide bridges are necessary for dimeriza-
tion of the S100 proteins, as covalent dimers by means of
sulphur bridges have been reported for human, mouse
and rabbit calcyclins. In the structure of psoriasin, there
is a very clear, fully occupied, intramonomer disulphide
bridge between the only two cysteine residues in the
protein, Cys46 and Cys95, and it is undoubtedly possible
for the protein to form a non-covalent dimer. A non-
covalently bound dimer was also reported for S100B, but
in this case the cysteines (Cys68 and Cys84) were too
far apart (about 21 Å) to form the disulphide bond. It
was argued, however, that conformational changes upon
calcium-binding might bring the two cysteines into close
vicinity and allow a disulphide bridge form [5]. In the
light of the apparent structural similarities between the
cation-bound psoriasin and the apo S100B, conforma-
tional changes large enough to bring these two sulphur
atoms into bonding distance are not likely to occur upon
calcium binding. Moreover, disulphide linkage seems
not to be of any importance with respect to the calcium-
binding affinity of the S100 proteins.
Helix interaction in the dimer interface
The dimerization through tight helical packing seems to
be crucial for the native structure of the S100 proteins,
because when torn apart the monomers become highly
non-globular, with their helices I protruding. The inter-
monomer interface constitutes approximately 516 Å2 of
the total dimer surface area which is about 9170 Å2
(calculated with GRASP [24]). The packing of the two
monomers in the dimer is primarily stabilized by hydro-
phobic sidechains on the helices I and IV. All helix
packing is highly symmetric due to the antiparallel arrange-
ment of the helices. The inter-helical interaction between
the two helices IV of the two monomers is governed by
the symmetric stacking of Phe71 with His86 from both
molecules, as well as hydrophobic interaction mediated
through the sidechains of Leu75 and Ala82. The packing
of the two helices I is dominated by methionine residues
(Met12 and Met15 from each molecule making a total of
four sulphur atoms in the interface), the apparent inter-
action being Met12–Ile9 and Met15–Ala5. The packing
of the helices I seems to be less strong than that of
helices IV, as some of the methionine residues are disor-
dered: Met12 of the first monomer forms two completely
different rotamers, while Met15 of the other monomer
has a disordered sulphur position. Hydrophobic inter-
action between helices I and IV is achieved through
stacking of Phe16 (helix I, monomer 1) and His86 (helix
IV, monomer 2).
Most noteworthy is the fact that the two phenylalanines
which clearly contribute to the stacking interaction (Phe16
and Phe71) both are extremely conserved within the family.
Generally, the widely conserved hydrophobic residues
seem to be important for maintaining the core of the dimer,
as has been seen for other members of the family. These
conserved amino acids may prove to be key to understand-
ing why the S100 proteins have the same overall fold, in
spite of their apparent lack of sequence homology.
Biological implications
Psoriasin is a small calcium-binding protein and a
member of the S100 family of EF-hand proteins. It was
originally discovered because the expression levels of
this protein are greatly enhanced in the skin cells of
patients suffering from psoriasis, a hyperproliferative
skin disease characterized by abnormal differentiation
and epidermal infiltration of neutrophils and T-lympho-
cytes [25]. At present, very little is known about the
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Figure 4
Structural alignment of EF-hands. (a) A
structure-based alignment of the C-terminal
EF-hand of psoriasin (green) with its Ho ion
(white sphere), the empty N-terminal hand
(red), and the corresponding N-terminal hand
from the apo S100B structure (blue). The
alignment shows that even though the helices
are correctly oriented, the missing amino
acids in the N-terminal EF-hand of psoriasin
make the loop ‘cut short’ and thereby it is not
able to bind calcium (see text). (b) A similar
alignment of the C-terminal EF-hand of
psoriasin (green) with the C-terminal EF-hand
of apo S100B (blue), showing minor changes
in the orientation of the helices and the size of
the loop that could be related to the
binding–release of calcium (see text). Figure
produced with MOLSCRIPT [39] and
Raster3D [40,41].
molecular basis of this complex disease, although
numerous studies have been carried out in an effort to
identify growth factors and cell-adhesion molecules that
may play a role in the physiopathology of the disease.
Psoriasin was discovered by proteome profiling analysis
of non-cultured normal and psoriatic keratinocytes
[26,27], which has so far identified several proteins that
are disregulated in psoriatic lesions [28–30], but its
exact function is unknown at present.
This paper describes the X-ray crystal structure of
human psoriasin which represents the most accurately
determined structure of any calcium-binding protein. The
protein appears as a homodimer, which judging from the
structures of S100B and S100A6, seems to be the general
fold of the more typical S100 proteins. The dimer is clamp
shaped and seems to be able to accommodate the pro-
posed receptor protein within its cleft. Psoriasin differs
from the other S100 proteins of known structure mainly
in its low-affinity EF-hand at the N terminus, which
probably does not bind calcium at all. Even though the
sequence homology between psoriasin and the other S100
proteins is quite low, the conserved hydrophobic residues
in the regions flanking the EF-hands are conserved and
are important for stabilization of the dimer. Because pso-
riasin seems to lack the calcium-binding ability in one EF-
hand, the conserved hydrophobic core is probably a more
important characteristic of the S100 proteins than two
fully functional EF-hands.
The determination of the psoriasin structure by substitu-
tion of the intrinsic calcium ions for the heavier lan-
thanide elements is important from a methodological
point of view, as this provides a general strategy for
determination of the structures of other S100 proteins.
The precise phase information available through the
multiple wavelength (MAD) method offers an as yet
unsurpassed quality of the resulting electron-density
map. The resulting model is of much lower general error
in the atomic coordinates than similar structures deter-
mined by NMR spectroscopy.
Materials and methods
Metal ion substitution and crystallization
Recombinant psoriasin was expressed in Escherichia coli BL21 cells,
in vitro refolded in the presence of Ca2+ and purified essentially as
described previously [4]. Urea and EDTA (pH 8.0) were added to final
concentrations of 8 M and 20 mM, respectively, to 20 mg refolded
protein at 1 mg/ml in 20 mM Tris[hydroxymethyl]aminomethane-HCl
(Tris-HCl), pH 8.0, and 100 mM NaCl. After 20 min at room tempera-
ture, pH was lowered to 4.5 using 5M acetic acid and the resulting
denatured protein was passed through a Sephadex G25 gel filtration
column (Pharmacia, Sweden) into 8M urea, 50 mM NaCl and 20 mM
sodium acetate (pH 4.5). Divalent cations were removed from the
buffer prior to use by passing it through a carboxymethylated aspartic
acid (CM-Asp) affinity column [31] and the buffer was degassed with
helium before applying it to the G25 column. This was crucial to avoid
formation of holmium hydroxides of very low solubility. After gel filtra-
tion, a 0.4 M solution of HoCl3 (adjusted to pH 2.0 with HCl) was
added to the protein solution to a final concentration of 2 mM, before
changing the pH to 8 with 3M Tris-HCl. The protein was renatured by
gel filtration into 20 mM Tris-HCl (pH 8.0), 20 mM NaCl and 2 mM HoCl3
on the G25 Sephadex column. Divalent cations had again been
removed and the buffer degassed with helium prior to addition of the
holmium chloride solution. The protein peak was collected and concen-
trated on Centricon C-10 (Amicon, MA, USA) to 8.6 mg/ml as mea-
sured by the Bradford colorimetric method (BioRad, CA, USA).
Orthorhombic crystals (~1.0 mm · 0.1 mm · 0.05 mm) of the protein
were obtained in 4–10 m l sitting drops, which had been mixed in a 1:1
ratio with a reservoir containing 800–1000 m l of 20–30% (w/v)
PEGmmes 2000, 50–300 mM (NH4)2SO4 and 100 mM N-[2-hydrox-
yethyl]-piperazine-N¢ -[2-ethanesulphonic acid] (Hepes) or Na(CH3COO)
depending on the pH. Crystals appeared at room temperature over a
wide range of precipitant concentrations and pH (4.6–7.5). The crys-
tals were characterized on the in-house FAST area detector at room
temperature and belong to the spacegroup P212121 with approximate
cell dimensions a = 46.8 Å, b = 61.1 Å, c = 62.5 Å. Consequently, they
were not isomorphous with the orthorhombic crystals previously
obtained in our laboratory for the calcium binding form of psoriasin [14]
for which a = 52.15 Å, b = 56.67 Å, c = 76.38 Å, a fact that precluded
the determination of the structure by isomorphous replacement. The
density of the crystals was measured to 1.26 g/cm3 by use of an
orthoxylene/bromobenzene gradient which suggested that there could
be either two or three protomers per asymmetric unit. The crystals of the
cation-substituted psoriasin diffract extremely well and diffraction proba-
bly exceeds 1 Å at cryogenic temperature using synchrotron radiation.
Data collection
MAD data were collected on beamline X31 at the synchrotron source
at the EMBL-Hamburg, Germany, on a small 18 cm MAR image plate
detector. Crystals were initially placed in a cryoprotecting solution con-
taining 30% (w/v) PEGmmes 2000, 150 mM (NH4)2SO4, 100 mM
Hepes-KOH (pH 6.7) and 1% (v/v) glycerol for 10 minutes and then
quickly transferred to a similar solution with 10% (v/v) glycerol before a
single crystal was mounted in a loop, shock-frozen and kept at 100 K in
a nitrogen gas stream. Due to their natural elongated shape, the crys-
tals could readily be oriented with an axis almost parallel to the spin
axis of the goniometer, allowing nearly simultaneous recording of
Friedel mates. A near-parallel alignment was used, however, in order to
reduce the number of reflections missing due to the spin angle cusp.
As a result of technical limitations of the wavelength monochromator,
collection of MAD data at the strong LIII-edge of holmium was not pos-
sible, and thus the LII-edge was used. In order to both calibrate the
monochromator and determine the exact location of the edge, a fluo-
rescence scan was recorded on a single psoriasin crystal with a scintil-
lation counter mounted in a right angle to the incoming beam. The
recorded spectrum (Figure 5a) is on arbitrary scale due to the propor-
tionality of the fluorescence with the atomic absorption coefficient, m A.
Approximate scattering factors f¢ and f¢¢ could now be estimated from a
pseudo-absolute scaling of this curve to theoretical values (data not
shown). As can be seen from the figure, the edge exhibits a strong
white-line feature which resulted in large Bijvoet differences. The fluo-
rescence scan allowed the determination of the wavelengths to use for
the peak (1.3887 Å), the inflection point or edge (1.3893 Å) and the
remote (0.98 Å) wavelength. The MAD data set was recorded by the
rotation–oscillation method in frames of Dj = 1° with a crystal to film
distance of 100 mm and dose control. The three data sets were col-
lected, one at a time, and the monochromator was recalibrated for each
change of the wavelength. The resolution limit of the data sets at the
peak and the edge (1.9 Å) again reflect a technical limit, since at the
given wavelength (1.4 Å) higher resolution data could not be obtained
with the given cell parameters and beamline geometry. Integration,
scaling of the profile fitted intensities and merging of non-Friedel sym-
metry pairs was done separately for each wavelength with DENZO/
SCALEPACK [32], see Table 1. Friedel mates were then averaged and
intensities converted to structure factors with the CCP4 program
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TRUNCATE [15]. The fact that the approximation of |FT| as
½× (|F+|+|F–|) breaks down in presence of very high anomalous contri-
bution (like near the L-edges), was not taken into account during pro-
cessing of the Fridel mates for the initial structure solution and
refinement. For the final refinement run in SHELX, however, minimiza-
tion was done against separate Friedel mates and this significantly
lowered both R factors. The phasing procedure outlined below follows
the ‘merge first, phase later’ strategy.
A high resolution remote data set was collected at the X11 beamline
also at EMBL-Hamburg, where the higher intensity of the incoming
beam, the large MAR image plate and a wavelength of 0.9091 Å
allowed collection of data to 1.05 Å resolution (Table 1). To reduce
overlaps and overflow, the data was collected in three runs, the low
resolution range (50–2.8 Å, crystal-film 440 mm, Dj = 2°), the medium
resolution range (15–1.7 Å, crystal-film 250 mm, Dj = 2°), and finally
the high resolution data (5.3–1.05 Å, crystal-film 120 mm, Dj = 0.5°).
The signal to noise ratio (I/s I) remains above 4.0 in the outer resolution
shell (1.07–1.05 Å) and the Rsym is exceptionally low in this range
(about 10%), and from a plot of the I/s I versus resolution, the diffrac-
tion limit of this crystal can be estimated to about 1.00 Å. This high res-
olution data set was also processed with DENZO and SCALEPACK
[32] with the polarization of the beam taken into account for proper
scaling of data at such resolution.
Phasing
The anomalous signal was very large as expected and constitutes
almost 14% of the diffraction at the peak wavelength (Table 2). The
positions of the holmium atoms were calculated from the anomalous
Patterson at the peak wavelength. Both anomalous and dispersive Pat-
terson maps were virtually noise free and all self and cross-peaks could
easily be identified (Figure 5b). Due to the particular y-coordinates of
the two holmium atoms in the asymmetric unit which add up to 0.5, one
of the cross-peaks happens to lie in both v = ½ and w = ½ Harker sec-
tions. The position of the holmium atom corresponding to the strongest
of the self-peaks could be calculated manually, while the position of the
other holmium atom was determined from a difference Fourier map cal-
culated using the phase information from the first atom.
Phasing of the data was carried out with the CCP4 program
MLPHARE [15] which regards each of the wavelengths as a separate
derivative. Using the ANO option of the program, approximate scatter-
ing factors could be estimated, although these were significantly
biased by the absolute scale of the data. More precisely refined scat-
tering factors were obtained from heavy atom parameter refinement
with SHARP [17] (Table 2). As the summary in Table 2 shows, the
phasing resulted in an overall figure of merit (FOM) in the 0.8 range.
Model building and refinement
The tracing of the chain and building of the model could be carried
out immediately using the initial map from the phasing in MLPHARE,
calculated using the |FT| at the edge (reference) wavelength and the
calculated MAD phases, j T. The quality of the initial map even before
any kind of density modification was so excellent that all of the main-
chain, most sidechains and many solvent molecules could be identi-
fied in the completely experimental map (Figure 1a). After the model
had been built using the program O [33], it was initially subjected to
several cycles of least squares refinement with the refinement
program TNT [19] against the 1.7 Å remote data set from the MAD
data. During this process, the model was visually inspected several
times to track the progress of the refinement and to rebuild parts of
the model. No solvent was added during the refinement in TNT and
the two protomers in the asymmetric unit were restrained by non-
crystallographic symmetry (NCS). An individual isotropic B-factor
model was used throughout the initial refinement. The refinement
progress was always monitored by a cross-validating Rfree, calculated
from an independent set constituting 5% of the measured reflections
[34]. The initial model was improved from a R factor of 37% to
26.4% (with Rfree = 32.0%).
All subsequent refinement was carried out against the high resolution
data set to 1.05 Å with the SHELX-97 package [20,21] (for an overview,
see Figure 6a). Rebuilding of the model at all later stages was done in
the program O, using s A-weighted 2Fo–Fc maps [22] (Figure 1b).
Solvent positions were assigned automatically by SHELX, but always
checked in O for density and hydrogen bonding patterns at 3s in a s A-
weighted Fo–Fc difference map. The geometry was restrained using the
standard Engh and Huber restraints [35]. The temperature factor model
applied for the atomic resolution data included individual and anisotropic
B factors for all protein and solvent atoms. The anisotropy was restrained,
however, to describe similar shape (DELU) and have similar direction
(SIMU) for bonded atoms. For solvent, the anisotropy was restrained to
be spherical (ISOR). During the first 50 cycles, data from ¥ –1.6 Å was
used exclusively, and no solvent was added. The model from TNT was
improved significantly and the R factor dropped to 25.3% with
Rfree = 29.3%. The high resolution data (1.05 Å) was then introduced, the
most obvious water molecules gradually built and the NCS-restraint set
free. At this point, the R factor was 18.85% (Rfree = 21.84%). When the
anisotropic B factors were introduced, the R factor dropped more than
4% to 14.70% (Rfree = 18.15%). Disorder was now modelled for 19 of
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Figure 5
Fluorescence scan and Patterson map. (a) The fluorescence scan was
recorded from a single crystal of Ho-bound psoriasin at the holmium
LII-edge at ~1.39 Å and shows the white-line, which is exploited in
order to obtain the large anomalous differences at the peak and edge
wavelengths. (b) The Harker section (w = ½) of the observed peak
wavelength anomalous Patterson map (left) and the corresponding
calculated Patterson map representing the refined heavy-atom
parameters (right). Peaks 1 and 2 are the self-peaks of the two Ho
atoms (with 2 having somewhat lower occupancy), and 3 is a cross-
peak that happens to lie in both sections, v = ½ and w = ½. Both plots
are contoured from 2s with upwards intervals of 1s; they were
produced with FFT and NPO [15].
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Structure
the amino acids in the asymmetric unit and riding hydrogens were intro-
duced (R = 13.20%, Rfree = 16.55%). After addition of more well-defined
solvent the final model eventually had an R factor of 10.49% for all data
and a cross-validation Rfree of 14.12%. Figure 6a shows the development
of R and Rfree as the refinement proceeded, whereas Table 3 gives a
summary of the quality of the final model which contains two times all
amino acids from 1 to 100 and 387 solvent molecules. In the refined
model, the two holmium atoms in the asymmetric unit have non-unity
occupancies of 0.980 and 0.627, respectively, a fact that was evident
already from the anomalous difference Patterson. Since the occupancies
refine to lower values for the high resolution data set than for the MAD
data set, and because the soaking time of the cryoprotectant was longer
for the latter, it is concluded that the differences in occupancy is caused
by partial loss of holmium from the protein upon transfer to the holmium
free environment. The reason one molecule looses more of its heavy
atom than the other could relate to the different location of the two
monomers in the cell with respect to solvent channels.
The quality of the final model was assessed with the PROCHECK
program package [36] and built-in features of the SHELX-97 auxiliary
program SHELXPRO. Inspection of a Luzzati plot [37] shows that the
estimated root mean square error in the atomic coordinates of the model,
assuming perfect data, is close to 0.05 Å and still less than 0.06 Å for the
highest resolution shell (Figure 6b). The final model has all the residues in
the 98% core regions of the Jones–Kleywegt Ramachandran plot [38]
(Figure 7) and 92.1% in the core and 7.9% in the additional allowed
regions in the Ramachandran plot, calculated with PROCHECK.
Accession numbers
Full coordinates and measured intensities have been deposited in the
Brookhaven Protein Database (PDB) with accession code 1psr.
Note added in proof
After this paper was accepted for publication, a crystallographic
study of S100B was published (Matsumura, H., Shiba, T., Inoue, T.,
Harada, S. & Kai, Y. (1998). A novel mode of target recognition sug-
gested by the 2.0 Å structure of holo S100B from bovine brain.
Structure 6, 233–241). Furthermore, two solution structures of
calcium-bound S100B and S100A6 were reported (Smith, S.P. &
Shaw, G.S. (1998). A novel calcium-sensitive switch revealed by the
structure of human S100B in the calcium-bound form. Structure 6,
211–222.) and (Sastry, M., et al., & Chazin, W. (1998). The three-
dimensional structure of Ca2+-bound calcyclin: implications for Ca2+-
signal transduction by S100 proteins. Structure 6, 223–231.). 
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Figure 6
Refinement and Luzzati plot. (a) The progress of the refinement in
SHELX-97 [20,21]. The bold lines show the development of the
R factor (all data) and cross-validation Rfree throughout the refinement.
The thin (rising) line indicates the number of solvent molecules added
to the model at a given time. The arrows illustrate different stages in
the refinement and show the result of each action. (b) A Luzzati plot of
the R factor for all data between 37.5 and 1.05 Å against 1/d. From
the standard curves, it is evident that the root mean square coordinate
error of the psoriasin model, assuming perfect data, is between 0.05 Å
and 0.06 Å. Plots were produced with SHELXPRO [20,21].
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Figure 7
The Ramachandran plot for the final model. Non-glycine and non-
proline residues are indicated by solid circles (asparagine residues as
solid diamonds) and glycine residues as open squares. The shaded
area corresponds to the 98% core regions as defined by Kleywegt and
Jones [38]. Plot was created with rama (MK, unpublished program).
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